HSCS logo

Heart Test Laboratories (HSCS)

Profile

Full Name

HeartSciences Inc.

Ticker Symbol

HSCS

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

June 16, 2022

Indexes

Not included

Website

http://heartsciences.com

Employees

15

Key Details

Price

$3.22(-6.78%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$18.60K(+257.69% YoY)

Annual EPS

-$19.00(+76.25% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.22
HSCS price is $3.22

30-Day Relative Volume

0.36
HSCS 30-day relative volume is 0.36

Price Performance

Price Most recent change

-6.78%
HSCS price was down -6.78% on Apr 15, 2025

Price YTD change

-15.79%
HSCS price is down -15.79% since January 1st

Price 1-year change

-68.77%
HSCS price is down -68.77% year-on-year

Price 3-year change

-
HSCS price 3-year change is unknown

Price Range

Price All-time high

$600.00
HSCS price is currently -99.46% below its historical high of $600.00

Price 3-year low

$2.36
HSCS price is currently +36.31% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.48M
HSCS market capitalization is $3.48 million

Market cap 3-year change

-
HSCS market capitalization 3-year change is unknown

Market cap All-time high

$28.39M
HSCS market capitalization is currently -87.75% below its historical high of $28.39 million

Market cap sector rank

9.95%
HSCS market capitalization is higher than 9.95% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+64.87%
HSCS shares outstanding is up +64.87% year-on-year

Shares Outstanding 3-Year Change

-
HSCS shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.71
HSCS beta is 0.71

200-day SMA

$3.46
HSCS price is currently -7.14% below its 200-day simple moving average

50-day SMA

$3.25
HSCS price is currently -0.95% below its 50-day simple moving average

RSI

53.70
HSCS 14-day relative strength index is 53.70

Volume

0.36
HSCS 30-day relative volume is 0.36

ATR

$0.32
HSCS average true range is $0.32

10-day Historical Volatility

96.77%
HSCS 10-day historical volatility is 96.77%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$18.60K
HSCS annual revenue is $18.60 thousand

Revenue Analysts estimate

-
HSCS annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

+257.69%
HSCS annual revenue is up +257.69% year-on-year

Revenue Sector rank

3.13%
HSCS annual revenue is higher than 3.13% of companies in Healthcare sector

EPS

EPS

-$19.00
HSCS annual earnings per share is -$19.00

EPS Analysts estimate

-$9.54
HSCS annual earnings per share is currently +99.06% higher than the consensus analysts' forecast

EPS 1-year change

+76.25%
HSCS annual earnings per share is up +76.25% year-on-year

EPS Sector rank

7.79%
HSCS annual earnings per share is higher than 7.79% of companies in Healthcare sector

Profit

Gross profit

$12.50K
HSCS annual gross profit is $12.50 thousand

Gross margin

67.31%
HSCS annual gross profit margin is 67.31%

Operating profit

-$6.31M
HSCS annual operating income is -$6.31 million

Operating margin

-33.90K%
HSCS annual operating profit margin is -33.90 thousand%

Net income

-$6.61M
HSCS annual net profit is -$6.61 million

Net margin

-35.51K%
HSCS annual net profit margin is -35.51 thousand%

Expenses

Total expenses

$6.32M
HSCS annual total expenses is $6.32 million

Operating expenses

$6.32M
HSCS annual total operating expenses is $6.32 million

Cost of goods sold

$6100.00
HSCS annual cost of goods sold is $6100.00

Selling, general & administrative expenses

$3.44M
HSCS annual SGA is $3.44 million

Depreciation and amortization

$95.10K
HSCS annual depreciation & amortization is $95.10 thousand

Interest expense

$354.10K
HSCS annual interest expense is $354.10 thousand

Income tax

-
HSCS annual income tax value is unknown

EBIT & EBITDA

EBIT

-$6.25M
HSCS annual earnings before interest & taxes is -$6.25 million

EBITDA

-$6.16M
HSCS annual EBITDA is -$6.16 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$9.50M
HSCS annual total assets is $9.50 million

Non current assets

$2.15M
HSCS annual long term assets is $2.15 million

Current assets

$7.35M
HSCS annual total current assets is $7.35 million

Cash and cash equivalents

$5.81M
HSCS annual cash & cash equivalents is $5.81 million

Accounts receivable

-
HSCS annual accounts receivable value is unknown

Inventory

$629.20K
HSCS annual inventory is $629.20 thousand

Liabilities

Total liabilities

$2.19M
HSCS annual total liabilities is $2.19 million

Long term liabilities

$434.00K
HSCS annual total long term liabilities is $434.00 thousand

Current liabilities

$1.75M
HSCS annual total current liabilities is $1.75 million

Accounts payable

$448.20K
HSCS annual accounts payable is $448.20 thousand

Debt

Total debt

$1.04M
HSCS annual total debt is $1.04 million

Total debt 1-year change

-33.82%
HSCS annual total debt is down -33.82% year-on-year

Long term debt

$434.00K
HSCS annual long term debt is $434.00 thousand

Short term debt

$602.30K
HSCS annual short term debt is $602.30 thousand

Equity & Capital

Shareholders equity

$7.32M
HSCS annual stockholders equity is $7.32 million

Book value

$7.32M
HSCS annual book value is $7.32 million

Retained earnings

-$67.36M
HSCS annual retained earnings is -$67.36 million

Working capital

$5.60M
HSCS annual working capital is $5.60 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$6.07M
HSCS annual cash flow from operations is -$6.07 million

Cash from operations 1-year change

-5.14%
HSCS annual cash flow from operations is down -5.14% year-on-year

Cash from investing

-$125.30K
HSCS annual cash flow from investing activities is -$125.30 thousand

Cash from investing 1-year change

-584.7%
HSCS annual cash flow from investing activities is down -584.7% year-on-year

Cash from financing

$10.34M
HSCS annual cash flow from financing activities is $10.34 million

Cash from financing 1-year change

+58.29%
HSCS annual cash flow from financing activities is up +58.29% year-on-year

CAPEX

CAPEX

$125.30K
HSCS annual capital expenditures is $125.30 thousand

CAPEX 1-year change

+584.7%
HSCS annual capital expenditures is up +584.7% year-on-year

Free Cash Flow

Free cash flow

-$6.20M
HSCS annual free cash flow is -$6.20 million

Free cash flow 1-year change

-6.97%
HSCS annual free cash flow is down -6.97% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

67.31%
HSCS annual gross profit margin is 67.31%

Operating margin

-33.90K%
HSCS annual operating profit margin is -33.90 thousand%

Net margin

-35.51K%
HSCS annual net profit margin is -35.51 thousand%

ROA & ROE

ROA

-103.28%
HSCS annual return on assets is -103.28%

ROE

-175.02%
HSCS annual return on equity is -175.02%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
HSCS price to earnings ratio value is unknown

PE ratio Sector rank

-
HSCS price to earnings ratio is unknown

PB Ratio

PB ratio

1.95
HSCS price to book ratio is 1.95

PB ratio Sector rank

61.4%
HSCS price to book ratio is higher than 61.4% of companies in Healthcare sector

PS Ratio

PS ratio

-
HSCS price to sales ratio value is unknown

PS ratio Sector rank

-
HSCS price to sales ratio is unknown

Enterprise value

Enterprise value

$3.87M
HSCS enterprise value is $3.87 million

Enterprise value Sector rank

17.87%
HSCS enterprise value is higher than 17.87% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.48
HSCS EV/EBITDA is -0.48

EV/EBITDA Sector rank

52.05%
HSCS EV/EBITDA is higher than 52.05% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.20
HSCS annual current ratio is 4.20

Quick ratio

3.84
HSCS annual quick ratio is 3.84

Leverage

Debt to equity

0.07
HSCS annual debt to equity ratio is 0.07

Interest coverage ratio

-17.65
HSCS annual interest coverage ratio is -17.65

Risk & Stability

Piotroski F-Score

-
HSCS piotroski f-score value is unknown

Altman Z-Score

-10.43
HSCS altman z-score is -10.43

Analyst ratings

Recent major analysts updates

Mar 18, 25 Ascendiant Capital
Buy
Dec 18, 24 Maxim Group
Buy
Sep 23, 24 Ascendiant Capital
Buy
Jan 30, 23 Ascendiant Capital
Buy
Dec 19, 22 Maxim Group
Buy
Nov 9, 22 Maxim Group
Buy
Aug 8, 22 Benchmark
Speculative Buy

Institutional Ownership

Similar stocks

QNRX logo
Quoin Pharmaceuticals (QNRX)
ATNF logo
180 Life Sciences (ATNF)
XYLO logo
Xylo Technologies (XYLO)
NBY logo
NovaBay Pharmaceuticals (NBY)
XRTX logo
XORTX Therapeutics (XRTX)
TTNP logo
Titan Pharmaceuticals (TTNP)
GLTO logo
Galecto (GLTO)
ATIP logo
ATI Physical Therapy (ATIP)
KTTA logo
Pasithea Therapeutics (KTTA)
  • What is the ticker symbol for Heart Test Laboratories?
  • Does Heart Test Laboratories pay dividends?
  • What sector is Heart Test Laboratories in?
  • What industry is Heart Test Laboratories in?
  • What country is Heart Test Laboratories based in?
  • When did Heart Test Laboratories go public?
  • Is Heart Test Laboratories in the S&P 500?
  • Is Heart Test Laboratories in the NASDAQ 100?
  • Is Heart Test Laboratories in the Dow Jones?
  • When does Heart Test Laboratories report earnings?
  • Should I buy Heart Test Laboratories stock now?

What is the ticker symbol for Heart Test Laboratories?

The ticker symbol for Heart Test Laboratories is NASDAQ:HSCS

Does Heart Test Laboratories pay dividends?

No, Heart Test Laboratories does not pay dividends

What sector is Heart Test Laboratories in?

Heart Test Laboratories is in the Healthcare sector

What industry is Heart Test Laboratories in?

Heart Test Laboratories is in the Medical Devices industry

What country is Heart Test Laboratories based in?

Heart Test Laboratories is headquartered in United States

When did Heart Test Laboratories go public?

Heart Test Laboratories's initial public offering (IPO) was on June 16, 2022

Is Heart Test Laboratories in the S&P 500?

No, Heart Test Laboratories is not included in the S&P 500 index

Is Heart Test Laboratories in the NASDAQ 100?

No, Heart Test Laboratories is not included in the NASDAQ 100 index

Is Heart Test Laboratories in the Dow Jones?

No, Heart Test Laboratories is not included in the Dow Jones index

When does Heart Test Laboratories report earnings?

The date for Heart Test Laboratories's next earnings report has not been announced yet

Should I buy Heart Test Laboratories stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page